Approved Ligands

Entacapone inhibits catechol-O-methyltransferase(COMT) with IC50 of 151 nM.A peripherally acting inhibitor of catechol-O-methyl transferase.

Entacapone inhibits catechol-O-methyltransferase(COMT) with IC50 of 151 nM.A peripherally acting inhibitor of catechol-O-methyl transferase.

Entacapone inhibits catechol-O-methyltransferase(COMT) with IC50 of 151 nM.A peripherally acting inhibitor of catechol-O-methyl transferase.

Entacapone inhibits catechol-O-methyltransferase(COMT) with IC50 of 151 nM.A peripherally acting inhibitor of catechol-O-methyl transferase.

Entacapone inhibits catechol-O-methyltransferase(COMT) with IC50 of 151 nM.A peripherally acting inhibitor of catechol-O-methyl transferase.

Enzalutamide (MDV3100) is an androgen-receptor (AR) antagonist with IC50 of 36 nM.An androgen receptor inhibitor.

Enzalutamide (MDV3100) is an androgen-receptor (AR) antagonist with IC50 of 36 nM.An androgen receptor inhibitor.

Enzalutamide (MDV3100) is an androgen-receptor (AR) antagonist with IC50 of 36 nM.An androgen receptor inhibitor.

Enzalutamide (MDV3100) is an androgen-receptor (AR) antagonist with IC50 of 36 nM.An androgen receptor inhibitor.

Enzalutamide (MDV3100) is an androgen-receptor (AR) antagonist with IC50 of 36 nM.An androgen receptor inhibitor.

Enzalutamide (MDV3100) is an androgen-receptor (AR) antagonist with IC50 of 36 nM.An androgen receptor inhibitor.

Erlotinib, Free Base, is the free base form of erlotinib hydrochloride (sc-202154), a small molecule EGFR/HER-1 (human epidermal growth factor receptor) tyrosine kinase reversible inhibitor.A tyrosine kinase inhibitor.